The Role and Clinical Relevance of Disseminated Tumor Cells in Breast Cancer

被引：19

作者：

Banys, Malgorzata ^{[1
,2
]}

Krawczyk, Natalia ^{[1
]}

Fehm, Tanja ^{[1
]}

机构：

[1] Univ Dusseldorf, Dept Obstet & Gynecol, D-40225 Dusseldorf, Germany

[2] Marien Hosp, Dept Obstet & Gynecol, D-22087 Hamburg, Germany

来源：

CANCERS | 2014年 / 6卷 / 01期

关键词：

breast cancer; bone marrow; disseminated tumor cell; circulating tumor cell; tumor cell dissemination; CIRCULATING EPITHELIAL-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; HER2; STATUS; MICROMETASTATIC CELLS; PROGNOSTIC RELEVANCE; RECEPTOR EXPRESSION; SYSTEMIC THERAPY; STAGE-I; RT-PCR;

D O I：

10.3390/cancers6010143

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tumor cell dissemination is a common phenomenon observed in most cancers of epithelial origin. One-third of breast cancer patients present with disseminated tumor cells (DTCs) in bone marrow at time of diagnosis; these patients, as well as patients with persistent DTCs, have significantly worse clinical outcome than DTC-negative patients. Since DTC phenotype may differ from the primary tumor with regard to ER and HER2 status, reevaluation of predictive markers on DTCs may optimize treatment choices. In the present review, we report on the clinical relevance of DTC detection in breast cancer.

引用

页码：143 / 152

页数：10

共 50 条

[21] Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Katharina E. Effenberger
Elin Borgen
Christine zu Eulenburg
Kai Bartkowiak
Andrea Grosser
Marit Synnestvedt
Rolf Kaaresen
Burkhard Brandt
Jahn M. Nesland
Klaus Pantel
Bjorn Naume
Breast Cancer Research and Treatment, 2011, 125 : 729 - 738
[22] Clinical Relevance of Early Disseminated Breast Cancer Cells Depends on Their Cytokeratin Expression Pattern.
Effenberger, K. E.
Borgen, E. F.
Bartkowiak, K.
zu Eulenburg, C.
Brors, B.
Kaaresen, R.
Nesland, J. M.
Pantel, K.
Naume, B.
CANCER RESEARCH, 2009, 69 (24) : 653S - 653S
[23] Circulating and Disseminated Tumor Cells in the Management of Breast Cancer
Ross, Jeffrey S.
Stodkowska, Elzbieta A.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 237 - 245
[24] Disseminated Tumor Cells and Dormancy in Breast Cancer Progression
Banys-Paluchowski, Malgorzata
Reinhardt, Florian
Fehm, Tanja
CIRCULATING TUMOR CELLS IN BREAST CANCER METASTATIC DISEASE, 2020, 1220 : 35 - 43
[25] Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential
Arkadius, Polasik
Marie, Tzschaschel
Fabienne, Schochter
Thomas, W. P. Friedl
Brigitte, Rack
Andreas, Hartkopf
Peter, A. Fasching
Andreas, Schneeweiss
Volkmar, Mueller
Jens, Huober
Wolfgang, Janni
Tanja, Fehm
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2019, 31 (01) : 76 - 81
[26] Clinical relevance of circulating tumor cells (CTC) in primary and metastatic breast cancer
Fehm, T.
EJC SUPPLEMENTS, 2009, 7 (04): : 3 - 4
[27] Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
Mostert, Bianca
Sleijfer, Stefan
Foekens, John A.
Gratama, Jan Willem
CANCER TREATMENT REVIEWS, 2009, 35 (05) : 463 - 474
[28] Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.
Hartkopf, Andreas D.
Banys, Malgorzata
Gebauer, Gerhard
Krawczyk, Natalia
Hahn, Markus
Neubauer, Hans
Wallwiener, Markus
Taran, Florin-Andrei
Wallwiener, Diethelm
Fehm, Tanja N.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[29] Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions
Amadori, A.
Rossi, E.
Zamarchi, R.
Carli, P.
Pastorelli, D.
Jirillo, A.
ONCOLOGY, 2009, 76 (06) : 375 - 386
[30] Disseminated and Circulating Tumour Cells and Their Role in Breast Cancer
Cabinakova, M.
Tesarova, P.
FOLIA BIOLOGICA, 2012, 58 (03) : 87 - 97

← 1 2 3 4 5 →